OptiMedica

OptiMedica Corporation is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. The company was founded in 2004 with the vision of bringing innovative new technologies to ophthalmologists and transforming existing standards of care.

Since its founding, OptiMedica has been developing a reproducible, noninvasive technique to replace the inconsistent manual steps in cataract surgery with femtosecond laser technology. The system has been designed to deliver new levels of precision, control, performance, and efficacy to cataract surgeons and their patients. OptiMedica has completed clinical trials of its Catalysâ„¢ Precision Laser System, with very promising results reported across these measures. While the Catalys Precision Laser System is not currently for sale in the United States, OptiMedica expects to launch the system in U.S. and international markets in 2011.

OptiMedica headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $5.1B in funding across 60 round(s). With a team of 10001+ employees, OptiMedica is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - OptiMedica, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.